When Cancer is no longer the biggest threat: AMR’s growing shadow over oncology
In 2025, it is possible — and increasingly common — [...]
The INCATE Management Team is growing!
At INCATE, we are committed to providing support to early-stage [...]
From lab to listing: CEO Marc Gitzinger on BioVersys’ IPO Journey
On February 7, 2025, Swiss biopharmaceutical innovator BioVersys made its [...]
Dancing against superbugs: a night of art, science, and urgent conversations in Basel
On the evening of April 9, 2025, The Voltahalle in [...]
AdjuTec Pharma : APC148 shows promising results in first-in-human study
AdjuTec Pharma AS - 3rd place winner of the Poster [...]
9th AMR Conference, what a journey!
INCATE kicked off the AMR week in Basel with the [...]
A new chapter for Helmut!
Our colleague Helmut Kessmann has decided his time has come to [...]
4 new additions to our portfolio!
The INCATE Selection Committee selected the new 4 ventures for [...]
AMR Conference 2025: Poster Competition finalists announced!
The AMR Conference 2025 has reached another milestone as the [...]
A&J Science: exciting updates and new opportunities
A&J Science, an innovative biotech company based in South Korea [...]
